Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT03249285
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 300 participants
- Sponsor
- Ospedale San Raffaele
- Registry
-
NCT03249285
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT03249285. Randomized; no masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2018-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)
- Acronym
- PGX-HT
- Condition
- Hypertension
- Intervention (Drug)
- Peri
- Intervention (Drug)
- HCTZ
- Lead sponsor
- Ospedale San Raffaele
Record details
- Record id
cardio:ct-nct03249285- Content hash
62fe5385b6085a85973002b4296925090396e60538cb20fc752540485e13c776